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Methods: Aspiration of the IM cavities of 5 patients’ femurs
ith matched ICBMA was performed. The long-bone-fatty-bone-
arrow (LBFBM) aspirated was ﬁltered (70m) and the solid
raction digested for 60min (37 ◦C) with collagenase. MSCs
ere isolated from LBFBM-liquid/LBFBM-solid fractions and from
atched ICBMA. Enumeration of MSCs was achieved via colony-
orming-unit-ﬁbroblast (CFU-F) assay and ﬂow-cytometry on
resh sample using CD45low CD271+. MSCs were cultured by
irtue of their plastic adherence and passaged in standard, non-
aematopoietic media. Passaged (P2) cells were differentiated
owards osteogenic, adipogenic and chondrogenic lineages with
heir phenotype assessed using ﬂow-cytometry CD33, CD34, CD45,
D73, CD90, CD105.
Results: MSCs were isolated from all fractions. Using the CFU-F
ssay median number of colonies: ICBMA=8 (2–21), LBFBM-
iquid =14 (0–53), LBFBM-solid =116 (23–171)per200l of sample
ith MSC frequency, as percentage of total cells, using ﬂow-
ytometry, providing similar results.MSCs isolated from the LBFBM
hases appeared to be not inferior to ICBMA in terms of osteogenic,
hondrogenic or adipogenic differentiation. Passaged cells from all
ractions had a phenotype consistent with other reported sources.
Discussion: The IM cavity of the femur is a depot of MSCs
hich are closely associated with fat but are at least equiva-
ent to ICBMA in terms of osteogenic/chondrogenic differentiation.
ntramedullary cavities of long-bones are frequently accessed by
he orthopaedic/trauma surgeon and reaming/removal of IM con-
ents is necessary for the nailing/insertion of prostheses. Removal
f the LBFBM prior to standard reaming, using a syringe and suc-
ion tubing, is a ‘low-tech’ method of harvesting LBFBM that can be
rieﬂy digested to give high yields of MSC. The volumetric concen-
ration of MSCs within this fraction is signiﬁcantly higher than that
or ICBM (∼10 fold) and we postulate that this would aid its use as
n alternative for autologous/allogenous use.
Conclusion: High concentrations ofMSC can be achieved by brief
igestion of aspirated IM fat from the femur. These cells appear
ppropriate for orthopaedic applications.
oi:10.1016/j.injury.2010.07.470
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he reamer–irrigator–asiprator (RIA): a systematic review
eorge Cox (BMBS)a, Elena Jones (PhD)b, Dennis McGonagle
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AcademicDepartment of Trauma&Orthopaedics, School ofMedicine,
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-mail address: pgiannoudi@aol.com (P.V. Giannoudis).
Background: The ‘reamer–irrigator–aspirator’ (RIA) is an inno-
ation developed to reduce fat embolism (FE) and thermal necrosis
TN) that can occur during reaming/nailing of long-bone fractures.
ince its inception its indications have expanded to include the
reatment of post-operative osteomyelitis and as a harvester of
one-graft/mesenchymal-stem-cells (MSCs).
Purpose: To review the sources reporting on this device and
omment on its effectiveness to (1) prevent FE and TN; (2) treat
ost-operative osteomyelitis; (3) harvest bone-graft andMSCs; and
4) operate safely.1 (2010) 131–166
Methods: A systematic review via pubmed and google scholar
using the keywords ‘reamer’, ‘irrigator’ and ‘aspirator’.
Results: Experimental data supports the use of the RIA in pre-
venting FE and TN, however, there is a paucity of clinical data.
The RIA is a reliable method in achieving high volumes of bone-
graft and MSCs. High union rates are reported when using RIA
bone-fragments to treat non-unions, however, papers are subject
to confounding factors. Evidence suggests possible effectiveness in
treating post-operative ostemyelitis. The RIA appears safe, with a
low rate of morbidity provided a meticulous technique is used.
Conclusions: Current evidence suggests that the RIA is safe to
use and effective in (1) preventing FE and TN; (2) treating post-
operative osteomyelitis; (3) harvesting bone-graft and MSCs. This
RIA demands further investigation especially with respect to the
optimal application of MSCs for bone repair strategies.
Conﬂict of interest: The authors declare that there is no conﬂict
of interest.
Ethical statement: Not applicable.
Work attributed to: Academic Unit, Trauma and Orthopaedic
Surgery, Clarendon Wing, Leeds General Inﬁrmary, Great George
Street, Leeds, LS1 3EX, UK.
doi:10.1016/j.injury.2010.07.471
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Introduction: There are currently two prognostic tools available
for predicting outcome in traumatic brain injury (TBI). The ﬁrst
involves prognostic models combining clinico-demographic char-
acteristics of patients for outcome prediction, whilst the second
employs serumbrain injurybiomarkers. S100B is awidelyacknowl-
edged biomarker of brain injury.
Objective: To identify which method has better prognostic
strengthandexplorehowcombining thesemethodsmight improve
the prognostic strength.
Methods: We analysed data from 100 TBI patients, all of whom
were admitted to the intensive care unit and had venous S100B
levels recorded at 24-h after injury. TBI prognostic models A and B,
constructed in Trauma Audit and Research Network (TARN), were
run on the dataset and then S100B was added as an independent
predictor to each model. Furthermore, another model was devel-
oped containing only S100B and subsequently, other important TBI
predictors were added to assess their ability to enhance the predic-
tive power of this model. The outcome measures were survival and
favourable outcome at 3 months.
Results: Among all the prognostic variables (including age, cause
of injury,GCS, pupillary reactivity, Injury Severity Score (ISS) andCT
classiﬁcations); S100Bhas thehighest predictive strengthonmulti-
variate analysis. No difference between performance of prognostic
models or S100B in isolation was observed. Addition of S100B to
the prognostic models improves the performance (e.g. Area Under
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he roc Curve (AUC), R2 Nagelkerke and classiﬁcation accuracy of
ARN model A to predict survival increase from 0.64, 0.08 and
1% to 0.72, 0.20 and 74.7%, respectively). Similarly, the predic-
ive power of S100B increases by adding other predictors to S100B
e.g. AUC (0.69 versus 0.78), R2 Nagelkerke (0.15 versus 0.30) and
lassiﬁcation accuracy (73% versus 77%) for survival prediction).
Conclusion: S100B appears to be the strongest prognostic vari-
ble in TBI. A better prognostic tool than those which are currently
vailablemay be a combination of both clinic-demographic predic-
ors with S100B.
oi:10.1016/j.injury.2010.07.472
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Introduction: Haemorrhage is a leading cause of mortality in
rauma, with recent evidence emphasising the importance of
aemostatic resuscitation anduseofmassive transfusionprotocols.
ew studies have characterised massive blood transfusion (MBT)
ractice in United Kingdom (UK) trauma. This study describes the
raumaResearch andAudit Network (TARN) experience ofmassive
ransfusion over a 5-year period.
Methods: We analysed prospectively collected data from the
ARN database for patients presenting between 2005 and 2009.
BT was deﬁned as administration of 10 or more units of packed
ed cells within 24h. The prevalence of MBT was examined, and
atient characteristics, blood product usage and mortality com-
ared to non-MBT patients. Initial clinical and injury features
redictive of massive transfusion and risk factors predictive of
eath in MBT were also analysed using multivariate logistic regres-
ion.
Results: One hundred andﬁfty seven (0.4%) receivedMBT,with a
ortality rate of 40.3%. Median age of MBT patients was 39.5 years,
edian ISS was 27 and 78% were male. MBT patients were more
ikely to be younger, male and to have sustained more severe, pen-
trating or trunk trauma (p<0.01). No patients received platelets
nd FFP in 1:1 ratios with packed red cells. Multivariate analysis
howed: age OR 1.02 (1.005–1.025), admission pulse rate OR 1.02
1.016–1.029), systolic blood pressure OR 0.96 (0.969–0.981), and
njury type; thoracic OR 4.21 (2.706–6.536), abdominal OR 5.06
3.253–7.88), pelvisOR3.649 (2.02–6.591),were signiﬁcant predic-
ors of MBT. ISS and admission pulse rate were also independent
redictors of death in MBT, but level of platelet and FFP use were
ot found to be statistically signiﬁcant.
Conclusion:MBT is a rareeventwithhighmortality inUKtrauma.
aemostatic resuscitation is not currently practiced in the UK and
e were unable to show that FFP and platelet use were signiﬁcant
redictors of survival in MBT.
oi:10.1016/j.injury.2010.07.4731 (2010) 131–166 157
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Objective: To analyse the prognostic power of various GCS com-
ponents and combinations of components in traumatic brain injury
patients and to investigate which time point of GCS measurement
(at scene versus on admission to the Emergency Department (ED))
has more prognostic strength.
Methods: Records of patients with brain injury since 1989 were
extracted from the Trauma Audit and Research Network (TARN)
database. Using logistic regression, a baseline model was derived
with age and Injury Severity Score (ISS) as regressors and discharge
outcome (survival) as the dependent variable. Total GCS, its compo-
nents and their combinationswere separately added to thebaseline
model in order to compare their effect on model performance.
Results: 21454 cases with brain injury were analysed. The eye
subscore has signiﬁcantly lower performance compared to total
GCS, motor score and various combinations of GCS subscores [e.g.
eye subscore: AUC of 0.89 (95% CI: 0.89–0.90) and Nagelkerke R2
of 0.53, total GCS: AUC of 0.91(95% CI: 0.91–0.92) and Nagelk-
erke R2 of 0.58]. The total GCS and the motor subscore have the
same predictive strength. Furthermore, the total GCS score at scene
and its components hold signiﬁcantly lower predictive power as
compared to those recorded on arrival at ED [scene total GCS:
AUC: 0.89(95% CI: 0.89–0.90) and Nagelkerke R2 of 0.54, arrival
total GCS: AUC of 0.91 (95% CI: 0.91–0.92) and Nagelkerke R2
of 0.58].
Conclusion: Signiﬁcantly lower predicative performance of the
eye subscore may indicate the need for a surrogate scale when
collection of both motor and verbal response is not reliable due
to paralysis and intubation. Further, better predicative strength of
admission scores than scene scores may be due to less accurate
measurement ofGCS at scene. This highlights the importance of ini-
tiatives to improve GCS collection at scene since GCS affects critical
decisions as to ﬁeld endotracheal intubation or triage for referral
to the trauma centres.
doi:10.1016/j.injury.2010.07.474
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Traditional tabletop exercises, that facilitatemajor incident (MI)
planning and education, use paper plans andmodels.Wedescribe a
low-cost, electronicwhiteboard that explores how interactive soft-
